Skip to main content
. 2018 Aug 20;18:118. doi: 10.1186/s12883-018-1121-5

Table 1.

Comparison of baseline characteristics between patients with normal and elevated hs-cTnT group

hs-cTnT< 14 ng/L (398) hs-cTnT≥14 ng/L (118) OR(95%CI) P*
Age, y(mean,SD) 65.36 ± 10.07 69.01 ± 9.77 0.00
Females,n(%) 205 (51.51) 58(49.15) 0.91 (0.60–1.37) 0.65
Men,n(%) 193(48.49) 60(50.85) 0.91(0.60–1.37) 0.65
Hypertension,patients,n(%) 287(72.11) 80(67.80) 0.81(0.52–1.27) 0.36
Current Smoking,n(%) 111(27.89) 38(32.20) 1.23(0.79–1.92) 0.36
Current alcohol drinking,n(%) 115(28.89) 38(32.20) 1.17(0.75–1.82) 0.49
Diabetes, n(%) 115(28.89) 39(33.05) 1.22(0.78–1.89) 0.39
Hyperlipidemia,n(%) 214(53.77) 60(50.85) 0.89(0.59–1.34) 0.58
ST/T change, n(%) 110 (27.64) 39(33.05) 1.293(0.83–2.01) 0.23
Insular stroke,n(%) 89(22.36) 63(53.39) 3.98(2.58–6.12) 0.00
Family history of stroke, n(%) 74(18,59) 27(22.88) 1.30(0.79–2.14) 0.30
NIHSS score(min-max) 2–25 2–30
NIHSS score(mean,SD) 8.82 ± 4.39 11.80 ± 5.21 0.00

*Comparison between normal hs-cTnT group and elevated hs-cTnT group